Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
Howard Trachtman, Hailey Desmond, Amanda Williams, et al.
Kidney International (2024) Vol. 105, Iss. 2, pp. 218-230
Open Access | Times Cited: 10

Showing 10 citing articles:

Challenges and Opportunities for the Clinical Translation of Spatial Transcriptomics Technologies
Kelly D. Smith, David K. Prince, James W. MacDonald, et al.
Glomerular Diseases (2024) Vol. 4, Iss. 1, pp. 49-63
Open Access | Times Cited: 10
Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy
Howard Trachtman, Radko Komers, Jula K. Inrig
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 6, pp. 571-576
Open Access | Times Cited: 6
Traditional, alternative, and emerging therapeutics for focal segmental glomerulosclerosis
Silvia Di Carlo, Elisa Longhitano, Claudia Spinella, et al.
Expert Opinion on Pharmacotherapy (2025), pp. 1-8
Closed Access
Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury
Yan Zhu, Gaosi Xu
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 857-875
Open Access
Sparsentan clinical trials in glomerular diseases: defining endpoints and a path forward in light of the parasol initiative
Howard Trachtman, Jula K. Inrig, Radko Komers
Future Rare Diseases (2025) Vol. 5, Iss. 1
Open Access
Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation
Yating Ge, Xue-qi Liu, Jinlian Shu, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1127-1142
Open Access
Decoding Glomerular disease: Baseline Profiles and Insights from the I-TANGIBLE Registry
Kavita Yadav, Raja Ramachandran, Vinod Kumar, et al.
Kidney International Reports (2025)
Open Access
Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluids
Sean Eddy, Viji Nair, John R. Hartman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Clinical Trials for Kidney Disease in the Era of Personalized Medicine
Hiddo J.L. Heerspink, Matthias Kretzler
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 8, pp. 1123-1126
Closed Access | Times Cited: 1
The Pursuit of New Treatments for FSGS: Harmonizing Innovation with the DUET Study of Sparsentan
Aparajita Mishra, Ai Itoku, Kimberly Reidy, et al.
Kidney Medicine (2024) Vol. 6, Iss. 6, pp. 100844-100844
Open Access
Page 1

Scroll to top